iCAD (ICAD) Revenue & Revenue Breakdown


OverviewOwnershipFinancialsChartTranscripts

iCAD Revenue Highlights


Latest Revenue (Y)

$17.32M

Latest Revenue (Q)

$4.95M

Main Segment (Y)

Product

Main Geography (Y)

Non-US

iCAD Revenue by Period


iCAD Revenue by Year

DateRevenueChange
2023-12-31$17.32M-38.03%
2022-12-31$27.94M-16.93%
2021-12-31$33.64M13.27%
2020-12-31$29.70M-5.24%
2019-12-31$31.34M22.32%
2018-12-31$25.62M-8.83%
2017-12-31$28.10M6.70%
2016-12-31$26.34M-36.62%
2015-12-31$41.55M-5.40%
2014-12-31$43.92M32.83%
2013-12-31$33.07M16.95%
2012-12-31$28.27M-1.32%
2011-12-31$28.65M16.59%
2010-12-31$24.58M-12.57%
2009-12-31$28.11M-25.03%
2008-12-31$37.49M40.88%
2007-12-31$26.61M34.94%
2006-12-31$19.72M-0.25%
2005-12-31$19.77M-15.18%
2004-12-31$23.31M257.47%
2003-12-31$6.52M30.40%
2002-12-31$5.00M3.41%
2001-12-31$4.84M-37.96%
2000-12-31$7.79M16.32%
1999-12-31$6.70M26.42%
1998-12-31$5.30M-32.91%
1997-12-31$7.90M-30.09%
1996-12-31$11.30M-45.15%
1995-12-31$20.60M-15.57%
1994-12-31$24.40M18.45%
1993-12-31$20.60M-

iCAD generated $17.32M in revenue during NA 2023, up -38.03% compared to the previous quarter, and up 67.59% compared to the same period a year ago.

iCAD Revenue by Quarter

DateRevenueChange
2024-03-31$4.95M4.49%
2023-12-31$4.74M16.40%
2023-09-30$4.07M-30.55%
2023-06-30$5.87M1.51%
2023-03-31$5.78M-10.96%
2022-12-31$6.49M2.09%
2022-09-30$6.36M-16.09%
2022-06-30$7.58M0.69%
2022-03-31$7.52M-3.65%
2021-12-31$7.81M-16.59%
2021-09-30$9.36M19.61%
2021-06-30$7.83M-9.46%
2021-03-31$8.64M-17.29%
2020-12-31$10.45M46.60%
2020-09-30$7.13M28.06%
2020-06-30$5.57M-15.02%
2020-03-31$6.55M-30.17%
2019-12-31$9.38M19.40%
2019-09-30$7.86M7.20%
2019-06-30$7.33M8.21%
2019-03-31$6.77M-2.60%
2018-12-31$6.95M12.31%
2018-09-30$6.19M0.49%
2018-06-30$6.16M-2.39%
2018-03-31$6.31M-20.11%
2017-12-31$7.90M12.89%
2017-09-30$7.00M9.22%
2017-06-30$6.41M-5.63%
2017-03-31$6.79M-1.98%
2016-12-31$6.93M15.41%
2016-09-30$6.00M-18.54%
2016-06-30$7.37M22.04%
2016-03-31$6.04M-20.65%
2015-12-31$7.61M-20.59%
2015-09-30$9.58M-14.01%
2015-06-30$11.14M-15.71%
2015-03-31$13.22M0.42%
2014-12-31$13.16M4.72%
2014-09-30$12.57M30.05%
2014-06-30$9.67M13.46%
2014-03-31$8.52M-6.73%
2013-12-31$9.13M10.19%
2013-09-30$8.29M7.49%
2013-06-30$7.71M-2.75%
2013-03-31$7.93M1.43%
2012-12-31$7.82M-4.46%
2012-09-30$8.18M37.97%
2012-06-30$5.93M-6.50%
2012-03-31$6.34M-4.04%
2011-12-31$6.61M-17.91%
2011-09-30$8.05M21.16%
2011-06-30$6.65M-9.50%
2011-03-31$7.34M15.27%
2010-12-31$6.37M14.04%
2010-09-30$5.59M-8.38%
2010-06-30$6.10M-6.49%
2010-03-31$6.52M-19.58%
2009-12-31$8.11M14.10%
2009-09-30$7.11M24.02%
2009-06-30$5.73M-20.03%
2009-03-31$7.16M-23.09%
2008-12-31$9.32M-16.77%
2008-09-30$11.19M6.11%
2008-06-30$10.55M64.02%
2008-03-31$6.43M-20.60%
2007-12-31$8.10M-

iCAD generated $4.95M in revenue during Q1 2024, up 4.49% compared to the previous quarter, and up 76.34% compared to the same period a year ago.

iCAD Revenue Breakdown


iCAD Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Product$9.93M$15.40M---
Service$7.39M----
Detection--$22.02M$22.00M$22.32M
Therapy--$11.62M$7.70M$9.02M

iCAD's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (57.34%), and Service (42.66%).

Quarterly Revenue by Product

Product/ServiceJun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19
Product$3.25M$3.10M$2.34M$2.20M$2.64M$2.74M$3.16M-------------
Service Contracts$1.77M$1.85M------------------
Therapy-------$2.00M$2.29M$2.00M$2.30M$3.35M$3.04M$2.92M$2.34M$1.84M$1.45M$2.08M$2.53M$1.77M
Detection-------$4.36M$5.29M$5.52M$5.50M$6.01M$4.79M$5.72M$8.11M$5.29M$4.12M$4.48M$6.86M$6.09M

iCAD's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product (64.70%), and Service Contracts (35.30%).

iCAD Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 21Dec 20Dec 19Dec 18
Non-US$7.50M$6.10M$3.80M$3.20M

iCAD's latest annual revenue breakdown by geography, as of Dec 21: Non-US (100.00%).

iCAD Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
NVRONevro$425.17M$101.90M
FNAParagon 28$216.39M$61.02M
ESTAEstablishment Labs$165.15M$44.12M
AXGNAxoGen$159.01M$47.91M
SIBNSI-BONE$138.89M$39.97M
SRDXSurmodics$132.58M$30.34M
SIENSientra$90.55M$19.54M
SRGASurgalign$81.98M$16.75M
SGHTSight Sciences$81.06M$21.37M
AZYOElutia$49.19M$6.13M
LNSRLENSAR$42.16M$10.59M
CVRXCVRx$39.30M$11.81M
SSKNSTRATA Skin Sciences$33.36M$8.44M
ICADiCAD$17.32M$4.95M
PROFProfound Medical$7.33M$1.90M
INVOINVO Bioscience$3.02M$1.58M
AIMDAinos$122.11K-
NVNOenVVeno Medical--
MOVEMovano--
BMRABiomerica-$1.02M

ICAD Revenue FAQ


iCAD's yearly revenue for 2023 was $17.32M, representing a decrease of -38.03% compared to 2022. The company's yearly revenue for 2022 was $27.94M, representing a decrease of -16.93% compared to 2021. ICAD's yearly revenue for 2021 was $33.64M, representing an increase of 13.27% compared to 2020.

iCAD's quarterly revenue for Q1 2024 was $4.95M, a 4.49% increase from the previous quarter (Q4 2023), and a -14.26% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $4.74M, a 16.40% increase from the previous quarter (Q3 2023), and a -26.94% decrease year-over-year (Q4 2022). ICAD's quarterly revenue for Q3 2023 was $4.07M, a -30.55% decrease from the previous quarter (Q2 2023), and a -35.92% decrease year-over-year (Q3 2022).

iCAD's revenue growth rate for the last 3 years (2021-2023) was -48.52%, and for the last 5 years (2019-2023) was -44.74%.

iCAD's revenue streams in c 23 are Product, and Service. Product generated $9.93M in revenue, accounting 57.34% of the company's total revenue, down -35.51% year-over-year. Service generated $7.39M in revenue, accounting 42.66% of the company's total revenue

For the fiscal year ending Dec 23, the largest source of revenue of iCAD was Product. This segment made a revenue of $9.93M, representing 57.34% of the company's total revenue.